SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,561,000 | +108.4% | 7,976 | +22.8% | 0.01% | -12.5% |
Q2 2020 | $749,000 | 0.0% | 6,495 | 0.0% | 0.02% | +100.0% |
Q1 2020 | $749,000 | +13.8% | 6,495 | +12.7% | 0.01% | +60.0% |
Q4 2019 | $658,000 | +44.6% | 5,762 | +8.0% | 0.01% | +25.0% |
Q3 2019 | $455,000 | +33.8% | 5,333 | +8.5% | 0.00% | +33.3% |
Q2 2019 | $340,000 | -5.8% | 4,915 | -0.2% | 0.00% | 0.0% |
Q1 2019 | $361,000 | +29.4% | 4,925 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $279,000 | -22.9% | 4,925 | +4.9% | 0.00% | 0.0% |
Q3 2018 | $362,000 | +24.0% | 4,695 | +6.8% | 0.00% | +50.0% |
Q2 2018 | $292,000 | +27.0% | 4,395 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $230,000 | +32.2% | 4,395 | +35.2% | 0.00% | +100.0% |
Q4 2017 | $174,000 | +20.8% | 3,250 | +22.6% | 0.00% | 0.0% |
Q3 2017 | $144,000 | +5.1% | 2,650 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $137,000 | -18.0% | 2,650 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $167,000 | +695.2% | 2,650 | +562.5% | 0.00% | – |
Q4 2016 | $21,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |